Autopsy report · NCT04638400
Anti-inflammatory Effects of Simvastatin
Cause of deathSlow enrollment
“Lack of recruitment- Fellow responsible for study graduated”
Life of this trial
- Registered 3 years 5 months after it had already started.
- Ran for about 4 years 6 months before it stopped.
- 10 participants enrolled.
- Results were posted on the registry 2 years 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- paresh Dandona
- Sponsor type
- University, hospital or other
- Conditions
- Inflammation; Atherosclerosis; Hypercholesterolemia
- Interventions
- Simvastatin 40mg; Ezetimibe 10mg
- Participants
- 10
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
“Not enough study participants, difficulties in recruitment” - Tele-health Enabled Clinical Trial for COVID-19
“Unable to overcome hurdles to study recruitment” - A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
“Unable to meet the study's recruitment goals” - Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females
“Poor recruitment to the study” - Use of Patient-Controlled Analgesia in Acute Pancreatitis
“inadequate recruitment despite efforts”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.